HOME >> MEDICINE >> NEWS
NIAID Ebola vaccine enters human trial

The first human trial of a vaccine designed to prevent Ebola infection opened today. Scientists from the Vaccine Research Center (VRC) at the National Institute of Allergy and Infectious Diseases (NIAID), one of the National Institutes of Health (NIH), designed the vaccine, which was administered to a volunteer at the NIH Clinical Center in Bethesda. The vaccine does not contain any infectious material from the Ebola virus.

Just three years ago, VRC Director Gary Nabel, M.D., Ph.D., together with a team of scientists from the VRC and the Centers for Disease Control and Prevention, described an experimental Ebola vaccine that fully protected monkeys from lethal infection by the virus. One component of that vaccine will now be assessed for safety in human volunteers. The trial vaccine, a type called a DNA vaccine, is similar to other investigational vaccines that hold promise for controlling such diseases as AIDS, influenza, malaria and hepatitis.

"This trial is further evidence of the ability of the VRC to rapidly translate basic research into tangible products," notes NIAID Director Anthony S. Fauci, M.D. "Our accelerated effort to understand and combat Ebola infection is part of the NIAID commitment to its biodefense mission. An effective Ebola vaccine not only would provide a life-saving advance in countries where the disease occurs naturally, it also would provide a
medical tool to discourage the use of Ebola virus as an agent of bioterrorism."

Outbreaks of Ebola in Africa kill up to 90 percent of those infected. No effective treatment exists for this highly infectious disease, which causes extensive internal bleeding and rapid death. According to experts, vaccination is the best strategy for preventing or containing this deadly infection.

A gap of two decades separated the first Ebola epidemic of 1976 and the next, which arose in 1995. In recent years, for reasons unknown, outbreaks of Ebola are occurring with increasing fre
'"/>

Contact: Contact: Anne A. Oplinger
aoplinger@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
18-Nov-2003


Page: 1 2 3

Related medicine news :

1. NIAID initiates trial of experimental avian flu vaccine
2. NIAID seeks applicants to lead clinical trials units for revamped HIV/AIDS networks
3. NIAID begins enrolling volunteers for novel HIV vaccine study
4. NIAID-sponsored clinical trial aims to boost flu vaccine supply
5. NIAID seeks applicants to lead revamped HIV/AIDS clinical trials networks
6. NIAID launches influenza genome sequencing project
7. NIAID launches program to improve medical tools against emerging infectious diseases
8. NIAID forms network to tackle potentially fatal reaction to smallpox vaccine
9. NIAID rotavirus vaccine licensed for commercialization
10. Second NIAID SARS vaccine candidate helps mice fend off SARS
11. NIAID vaccine protects against SARS virus infection in mice

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NIAID Ebola vaccine enters human trial

(Date:6/30/2015)... ... July 01, 2015 , ... Avid boxing style rock concert poster collector, Andrew ... concert posters. The Who and the Rascals also played at this concert in New ... Doors played with the Who backing them up. The Doors gave a very stirring ...
(Date:6/30/2015)... ... ... Carey Danis & Lowe comments on a new pretrial order ... court. The court document outlined the judge’s plan to consolidate 26 vaginal mesh lawsuits. ... & Lowe is a personal injury law firm with headquarters in St. Louis. The ...
(Date:6/30/2015)... ... , ... America is in a health crisis. Today, 4 out of 5 ... Why? , The answer is simple and is at the core of every disease ... treated over one million patients and, for the first time ever, gives readers and ...
(Date:6/30/2015)... ... ... they have slashed prices across the board for the Phantom of the Opera in ... “The Phantom of the Opera” has been a hit on musical stages around the United ... a musical by Andrew Lloyd Webber won a Tony Award for “Best Musical." The ...
(Date:6/30/2015)... ... , ... The American Institute of Personal Injury Attorneys (AIOPIA) awarded JTB Law Group, LLC as ... Attorney Award respectively. As of July 1, 2015, the firm and Mr. Brown personally ... New Jersey. The award is a culmination of the hard work, long hours, and ...
Breaking Medicine News(10 mins):Health News:Avid Boxing Style Rock Concert Poster Collector From Vintage Rock Posters Announces Search for 1968 Doors and Jimi Hendrix Singer Bowl Concert Posters 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 2Health News:Carey Danis & Lowe Comments on New Pretrial Order in Vaginal Mesh Lawsuit 3Health News:12 Easy-To-Follow Steps to Transform Body, Mind and Spirit 2Health News:Phantom of the Opera Tickets at The Pantages Theatre in Los Angeles: Ticket Down Has Slashed Prices On All Phantom of the Opera Tickets in LA at The Pantages Theatre 2Health News:JTB Law Group, LLC Recognized as a Top 10 Best Law Firm by AIOPIA 2
(Date:6/30/2015)... Legal-Bay LLC, the Lawsuit Settlement Funding Company, ... multidistrict litigation (MDL) over the Zimmer NexGen Knee implant ... , 2015. There are currently more than a thousand ... a federal judge in Illinois . ... begin in October of this year. Zimmer Inc. previously ...
(Date:6/29/2015)... -- , Gerresheimer will sell its borosilicate glass ... into a 10-year-supply agreement for pharmaceutical glass tubing ... Corning and Gerresheimer will form a joint ... Gerresheimer,s outlook for the financial years 2016 to ... tubing business , In line with its strategy ...
(Date:6/29/2015)... 29, 2015  PDL BioPharma, Inc. (NASDAQ: PDLI ... credit agreement with CareView Communications, Inc. (OTCQB: CRVW) whereby ... of secured debt financing. CareView is an information technology ... monitoring. Under the credit agreement, PDL will ... financing in two tranches of $20 million, based upon ...
Breaking Medicine Technology:Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 2Gerresheimer Will Sell Tubing Operations to Corning - Both Will Form a Joint Venture to Accelerate Innovations for Pharmaceutical Glass Packaging Market 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 2PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 3PDL BioPharma Announces $40 Million Financing Transaction with CareView Communications 4
Cached News: